Intervention not reported
Any reported infant death (fetal, neonatal, or before hospital discharge · pregnant women considered to be at risk of developing pre‐eclampsia
The intervention leads to lower any reported infant death (fetal, neonatal, or before hospital… (high certainty).
1 finding from 1 review
Intervention not reported
Preterm birth (before 37 weeks' gestation) · pregnant women considered to be at risk of developing pre‐eclampsia
The intervention leads to lower preterm birth (before 37 weeks' gestation) (high certainty).
1 finding from 1 review
Intervention not reported
Small‐for‐gestational age · pregnant women considered to be at risk of developing pre‐eclampsia
The intervention leads to lower small‐for‐gestational age (high certainty).
1 finding from 1 review
Intervention not reported
Pregnancy with serious adverse outcome (composite including maternal death, baby death, pre‐eclampsia, small‐for‐gestational age, preterm birth) ‐ only trials with individual participant data · pregnant women considered to be at risk of developing pre‐eclampsia
The intervention leads to lower pregnancy with serious adverse outcome (composite including maternal… (high certainty).
1 finding from 1 review
Intervention not reported
Postpartum haemorrhage > 500 mL · pregnant women considered to be at risk of developing pre‐eclampsia
The intervention showed no clear difference in postpartum haemorrhage > 500 mL (moderate certainty).
1 finding from 1 review
Intervention not reported
Placental abruption · pregnant women considered to be at risk of developing pre‐eclampsia
The intervention showed no clear difference in placental abruption (moderate certainty).
1 finding from 1 review
Thrombosis · people with antiphospholipid antibodies and no history of thrombosis
Anticoagulant with or without ASA showed no clear difference in thrombosis Median compared with ASA only (low certainty).
1 finding from 1 review
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event other than bleeding · people with antiphospholipid antibodies and no history of thrombosis
1 finding from 1 review
no estimate extracted
5 participants
GRADE not reported
Thrombosis · people with antiphospholipid antibodies and no history of thrombosis
1 finding from 1 review
Bleeding ‐ major (bleeding requiring transfusion) Length of · people with antiphospholipid antibodies and no history of thrombosis
ASA with LMWH showed no clear difference in bleeding ‐ major (bleeding requiring transfusion) Length of compared with placebo or IVIG (moderate certainty).
1 finding from 1 review
Bleeding ‐ other (bleeding during first trimester) Length of · people with antiphospholipid antibodies and no history of thrombosis
ASA with LMWH showed no clear difference in bleeding ‐ other (bleeding during first trimester) Length of compared with placebo or IVIG (moderate certainty).
1 finding from 1 review
Bleeding ‐ other (postpartum haemorrhage) Length of · people with antiphospholipid antibodies and no history of thrombosis
ASA with LMWH showed no clear difference in bleeding ‐ other (postpartum haemorrhage) Length of compared with placebo or IVIG (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events other than bleeding · people with antiphospholipid antibodies and no history of thrombosis
1 finding from 1 review
no estimate extracted
1 study · 3 participants
GRADE not reported
Major bleeding · people with antiphospholipid antibodies and no history of thrombosis
1 finding from 1 review
Thrombosis · people with antiphospholipid antibodies and no history of thrombosis
1 finding from 1 review
Bleeding ‐ major/excessive · people with antiphospholipid antibodies and no history of thrombosis
1 finding from 1 review